Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Abbott in-licenses Stanford University biomarkers for prostate cancer

April 18, 2012

DFH Pharma and NIH collaborate on development of HIV drugs

April 18, 2012

Conformetrix enters first collaboration agreement

April 17, 2012

Merck & Co. gains worldwide rights to anticancer conjugate

April 17, 2012

Proteros and Eisai launch research collaboration

April 17, 2012

Vanda Pharmaceuticals acquires tachykinin NK1 receptor antagonist

April 17, 2012

Piramal Imaging acquires PET tracers from Bayer

April 16, 2012

AstraZeneca and DNDi enter drug screening collaboration

April 13, 2012

AnGes and BioLeaders enter agreement on oral vaccine for hypertension

April 13, 2012

Agreement seeks to develop companion diagnostic for Adcetris

April 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...